Chargement en cours...
Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors
Inhibition of immune checkpoint pathways in CD8(+) T cell is a promising therapeutic strategy for the treatment of solid tumors that has shown significant anti-tumor effects and is now approved by the FDA to treat patients with melanoma and lung cancer. However the response to this therapy is limite...
Enregistré dans:
| Publié dans: | Front Cell Dev Biol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5893801/ https://ncbi.nlm.nih.gov/pubmed/29670880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2018.00038 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|